Advertisement

Topics

How are ValiRx developing personalised medicines for the treatment of cancer?

19:00 EDT 24 Sep 2014 | PharmaTelevision

If you experience problems with the audio on this interview please use mp4 link.
bit.ly/1wQTjzx

Overzealous, rebellious or inappropriate activity by specific genes contributes to many diseases states including cancers, inflammatory conditions, Alzheimer’s and autoimmune diseases. During NLSD 2014 in Stockholm, George Morris, COO of ValiRx explains to Fintan Walton how ValiRx’s proprietary GeneICE technology enables selective silencing of the rebellion, preventing activity from the rebellious gene.

Original Article: How are ValiRx developing personalised medicines for the treatment of cancer?

NEXT ARTICLE

More From BioPortfolio on "How are ValiRx developing personalised medicines for the treatment of cancer?"

Quick Search
Advertisement

 

Relevant Topics

Neurology - Central Nervous System (CNS)
Alzheimer's Disease Anesthesia Anxiety Disorders Autism Bipolar Disorders Dementia Epilepsy Multiple Sclerosis (MS) Neurology Pain Parkinson's Disease Sleep Disorders Neurology is the branch of me...

Autoimmune Disorders
Autoimmune disorders are conditions that occurs when the immune system mistakenly attacks and destroys healthy body tissue. There are more than 80 different types of autoimmune disorders. Normally the immune system's white blood cells help protect ...

Bioinformatics
Bioinformatics is the application of computer software and hardware to the management of biological data to create useful information. Computers are used to gather, store, analyze and integrate biological and genetic information which can then be applied...